- Home
- » Tags
- » Traxoprodil
Top View
- (12) United States Patent (10) Patent No.: US 9.486.453 B2 Javitt (45) Date of Patent: Nov
- Focus on Rapid Antidepressant Treatments Cristina Cusin, MD Depression Clinical and Research Program Assistant Professor HMS
- Molecular and Cellular Mechanisms Underlying the Antidepressant
- LCI699 (Osilodrostat) a Phase III, Multi-Center, Double-Blind, Randomized
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Elsevier Editorial System(Tm) for Trends in Pharmacological Sciences Manuscript Draft
- Customs Tariff - Schedule
- Influence of the Selective Antagonist of the NR2B Subunit of the NMDA
- Influence of the Selective Antagonist of the NR2B Subunit of the NMDA
- ( 12 ) United States Patent
- Panels, Mini-Panels and Study Groupsdecember 4
- Review Article Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
- Mathew, S.J., Manji, H.K., & Charney, D.S. (2008). Novel Drugs And
- (12) United States Patent (10) Patent No.: US 8,907,101 B2 Beaudoin Et Al
- Cocaine Self-Administration Elevates Glun2b Within Dmpfc Mediating Heightened Cue- Elicited Operant Responding
- Roles of Glutamate Receptors in Parkinson's Disease
- Ketamine's Antidepressant Action: Beyond NMDA Receptor Inhibition
- A New Generation of Antidepressants: an Update on the Pharmaceutical
- Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
- Traxoprodil, a Selective Antagonist of the NR2B Subunit of the NMDA
- EEG Gamma Power Changes Following Administration of NMDA
- Ep 2593428 B1
- Predicting Volume of Distribution in Humans: Performance of in Silico Methods for a Large Set of Structurally Diverse Clinical Compounds S
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Neuroplasticity and the Next Wave of Antidepressant Strategies
- The Opposing Roles of Glun2c and Glun2d NMDA Receptor Subunits in Modulating Neuronal Oscillations
- The Involvement of the Kynurenine Pathway in Parkinson’S Disease in Vitro Models
- Current Neuropharmacology, 2017, 15, 57-70 REVIEW ARTICLE
- Novel Approaches for the Management of Depressive Disorders
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- A Pharmacological Interactome Between COVID-19 Patient Samples and Human Sensory Neurons Reveals Potential Drivers of Neurogenic
- MARTIGNONI, FELIPE VILLA.Pdf
- The Role of Glutamate in Neuronal Ischemic Injury: the Role of Spark in fire
- Molecular Mechanisms Underlying the Antidepressant Actions of Arketamine: Beyond the NMDA Receptor
- Ionotropic Glutamate Receptors